| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.3M | +17.1% | +39.0% |
| Cost of Revenue | $2.0M | +8.4% | +30.0% |
| Gross Profit | $4.2M | +21.8% | +43.8% |
| R&D Expense | $2.0M | -9.2% | -21.4% |
| SG&A Expense | $941K | -20.6% | -28.0% |
| Operating Income | -$198K | +85.4% | +92.4% |
| Net Income | -$645K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $1.9M | -22.5% | +5.4% |
| Inventory | $2.0M | +13.7% | +4.6% |
| Current Assets | $8.3M | -15.5% | -45.7% |
| Total Assets | $20.2M | -7.9% | -28.3% |
| Current Liabilities | $6.3M | -12.3% | -43.6% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.5M | — | — |
| Capital Expenditures | $1.2M | — | — |
| Investing Cash Flow | -$1.2M | — | — |
| Financing Cash Flow | -$295K | — | — |
| Free Cash Flow | -$3.7M | — | — |
| -37.0% |
| +91.0% |
| EPS (Basic) | -$0.06 | -20.0% | +91.5% |
| $16.2M |
| -7.1% |
| -29.5% |
| Stockholders' Equity | -$16.1M | -3.2% | -8.1% |